Your search returned 112 studies:
- Genetic Study of Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, or Multiple Myeloma
Conditions: Leukemia - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms
Location: San Francisco, California
- Study to Assess Compliance With Long-Term Mercaptopurine Treatment in Young Patients With Acute Lymphoblastic Leukemia in Remission
Conditions: Leukemia
Location: Oakland, California
- Study to Assess Compliance With Long-Term Mercaptopurine Treatment in Young Patients With Acute Lymphoblastic Leukemia in Remission
Conditions: Leukemia
Location: San Francisco, California
- Donor Stem Cell Transplant in Treating Young Patients With Myelodysplastic Syndrome, Leukemia, Bone Marrow Failure Syndrome, or Severe Immunodeficienc
Conditions: Congenital Amegakaryocytic Thrombocytopenia - Leukemia - Myelodysplastic Syndromes - Severe Congenital Neutropenia
Location: San Francisco, California
- Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia
Conditions: Cognitive/Functional Effects - Leukemia - Long-term Effects Secondary to Cancer Therapy in Children - Neurotoxicity - Psychosocial Effects of Cancer and Its Treatment
Location: San Francisco, California
- Molecular Epidemiology of Childhood Leukemia (Aka The California Childhood Leukemia Study)
Conditions: Leukemia - Acute Myelocytic Leukemia - Acute Lymphoblastic Leukemia - Acute Myelogenous Leukemia
Location: Berkeley, California
- Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
Conditions: Brain and Central Nervous System Tumors - Chronic Myeloproliferative Disorders - Leukemia - Long-term Effects Secondary to Cancer Therapy in Children - Lymphoma - Lymphoproliferative Disorder - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic S
Location: San Francisco, California
- A Trial of the Combination 5-azacitidine and Gemtuzumab Ozogamicin Therapy for Treatment of Relapsed Acute Myeloid Leukemia (AML)
Conditions: Acute Myeloid Leukemia
Location: Stanford, California
- Study of Blood Samples From Newborns With Down Syndrome
Conditions: Leukemia
Location: Oakland, California
- Study of Blood Samples From Newborns With Down Syndrome
Conditions: Leukemia
Location: San Francisco, California
- Pilot Lenalidomide in Adult Diamond-Blackfan Anemia Patients w/ RBC Transfusion-Dependent Anemia
Conditions: Anemia - Leukemia - Leukemia, Myelocytic, Acute - Dysmyelopoietic Syndromes
Location: Stanford, California
- Study to Investigate CAL-101 in Combination With Chemotherapeutic Agents and CD20 mAb in Patients With Relapsed or Refractory Indolent B-cell Non-Hodg
Conditions: Indolent Non-Hodgkin's Lymphoma - Chronic Lymphocytic Leukemia - Mantle Cell Lymphoma
Location: Palo Alto, California
- Post T-plant Infusion of Allogeneic Cytokine Induced Killer Cells as Consolidate Therapy in Myelodysplastic Syndromes/Myeloproliferative Disorders
Conditions: Neural Tube Defects - Anemia - Leukemia, Myeloid - Bone Marrow Transplant Failure - Myelodysplastic Syndromes (MDS) - Myeloproliferative Disorders
Location: Stanford, California
- Azacitidine + Lenalidomide Combo in the Elderly Previously Treated Acute Myeloid Leukemia (AML) & High-Risk Myelodysplastic Syndromes (MDS)
Conditions: Leukemia - Acute Myeloid Leukemia (AML) - Myelodysplastic Syndromes (MDS)
Location: Stanford, California
- Diagnostic Study of Patients With Acute Lymphoblastic Leukemia or Acute Promyelocytic Leukemia
Conditions: Leukemia
Location: San Francisco, California
- Allogeneic Transplantation Using TL1 & ATG for Older Patients With Hematologic Malignancies
Conditions: Blood Cancer - Leukemia
Location: Stanford, California
- Tacrolimus and Methotrexate With or Without Sirolimus in Preventing Graft-Versus-Host Disease in Young Patients Undergoing Donor Stem Cell Transplant
Conditions: Graft Versus Host Disease - Leukemia
Location: Oakland, California
- Tacrolimus and Methotrexate With or Without Sirolimus in Preventing Graft-Versus-Host Disease in Young Patients Undergoing Donor Stem Cell Transplant
Conditions: Graft Versus Host Disease - Leukemia
Location: San Francisco, California
- Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation Followed by Donor Bone Marrow Transplant, Mycophenolate Mofetil, and Cyclosporine
Conditions: Adult Acute Myeloid Leukemia in Remission - Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities - Adult Acute Myeloid Leukemia With Del(5q) - Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) - Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)
Location: Oakland, California
- S0535, Gemtuzumab and Combination Chemotherapy in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia
Conditions: Leukemia
Location: Stanford, California
- Combination Chemotherapy With or Without Lestaurtinib in Treating Infants With Newly Diagnosed Acute Lymphoblastic Leukemia
Conditions: Leukemia
Location: Oakland, California
- Combination Chemotherapy With or Without Lestaurtinib in Treating Infants With Newly Diagnosed Acute Lymphoblastic Leukemia
Conditions: Leukemia
Location: San Francisco, California
- Allogeneic HCT Using Nonmyeloablative Host Conditioning With TLI & ATG vs SOC in AML
Conditions: Leukemia, Myeloid - Leukemia - Acute Myeloid Leukemia (AML)
Location: Hayard, California
- Allogeneic HCT Using Nonmyeloablative Host Conditioning With TLI & ATG vs SOC in AML
Conditions: Leukemia, Myeloid - Leukemia - Acute Myeloid Leukemia (AML)
Location: Stanford, California
- Targeted, Dose-Escalated Intravenous Busulfan and Bolus Etoposide as Preparative Therapy for Patients With Acute Myeloid Leukemia Undergoing Autologou
Conditions: Acute Myelogenous Leukemia
Location: San Francisco, California
- Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Conditions: Leukemia - Lymphoma
Location: Oakland, California
- Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Conditions: Leukemia - Lymphoma
Location: San Francisco, California
- Collecting and Storing Samples of Bone Marrow and Blood From Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma
Conditions: Leukemia - Lymphoma
Location: San Francisco, California
- Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer
Conditions: Leukemia - Neoplasm of Uncertain Malignant Potential - Unspecified Childhood Solid Tumor, Protocol Specific
Location: Oakland, California
- Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer
Conditions: Leukemia - Neoplasm of Uncertain Malignant Potential - Unspecified Childhood Solid Tumor, Protocol Specific
Location: San Francisco, California
- Collecting and Storing Blood, Bone Marrow, and Other Samples From Patients With Acute Leukemia, Chronic Leukemia, or Myelodysplastic Syndromes
Conditions: Leukemia - Lymphoma - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms
Location: Mountain View, California
- Collecting and Storing Blood, Bone Marrow, and Other Samples From Patients With Acute Leukemia, Chronic Leukemia, or Myelodysplastic Syndromes
Conditions: Leukemia - Lymphoma - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms
Location: San Francisco, California
- Studying Tissue and Blood Samples From Patients With Acute Myeloid Leukemia
Conditions: Leukemia
Location: Mountain View, California
- Open-label Study to Evaluate the Safety, PK, and PD of MEK Inhibitor GSK1120212 in Subjects With Relapsed or Refractory Leukemias
Conditions: Leukemia-relapsed or Refractory - Cancer
Location: San Francisco, California
- Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL
Conditions: Relapsed T-Cell Acute Lymphoblastic Leukemia - Relapsed T-Cell Lymphoblastic Lymphoma
Location: Palo Alto, California
- Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL
Conditions: Relapsed T-Cell Acute Lymphoblastic Leukemia - Relapsed T-Cell Lymphoblastic Lymphoma
Location: San Francisco, California
- Targeted, Dose-Escalation Busulfan-Etoposide as Prep Regimen
Conditions: Acute Myeloid Leukemia
Location: San Francisco, California
- A Pharmacokinetic (PK) Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-positive (Ph+) Chronic Myelogenous Leukemia (CML) or Acut
Conditions: Chronic Myeloid Leukemia - Acute Lymphoblastic Leukemia
Location: Palo Alto, California
- An Extension Study for Patients Who Are Deriving Benefit With CAL-101 to Continue on Treatment at the End of the Current Study
Conditions: Chronic Lymphocytic Leukemia - Lymphoma, Non-Hodgkin - Acute Myeloid Leukemia - Multiple Myeloma
Location: Palo Alto, California
- Clofarabine, Cytarabine, and Filgrastim in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia, Advanced Myelodysplastic Syndrome, and/or Ad
Conditions: Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities - Adult Acute Myeloid Leukemia With Del(5q) - Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) - Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) - Adult Acute Myeloid Leukemia With t(16;16)
Location: Stanford, California
- Genome, Proteome and Tissue Microarray in Childhood Acute Leukemia
Conditions: Leukemia
Location: Stanford, California
- Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
Conditions: Leukemia
Location: Oakland, California
- Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
Conditions: Leukemia
Location: San Francisco, California
- MLN8237 in Treating Young Patients With Recurrent or Refractory Solid Tumors or Leukemia
Conditions: Brain and Central Nervous System Tumors - Childhood Germ Cell Tumor - Kidney Cancer - Leukemia - Liver Cancer - Neuroblastoma - Sarcoma
Location: Oakland, California
- MLN8237 in Treating Young Patients With Recurrent or Refractory Solid Tumors or Leukemia
Conditions: Brain and Central Nervous System Tumors - Childhood Germ Cell Tumor - Kidney Cancer - Leukemia - Liver Cancer - Neuroblastoma - Sarcoma
Location: San Francisco, California
- INCB18424 in Treating Young Patients With Relapsed or Refractory Solid Tumor, Leukemia, or Myeloproliferative Disease
Conditions: Chronic Myeloproliferative Disorders - Leukemia - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms - Unspecified Childhood Solid Tumor, Protocol Specific
Location: San Francisco, California
- Risk-Adapted Chemotherapy in Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia
Conditions: Leukemia
Location: Oakland, California
- Risk-Adapted Chemotherapy in Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia
Conditions: Leukemia
Location: San Francisco, California
- Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Conditions: Leukemia - Acute Myeloid Leukemia - Acute Nonlymphocytic Leukemia
Location: San Francisco, California
- A Study of the Safety and Pharmacokinetics of Escalating Doses of DCDT2980S in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma and
Conditions: Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia
Location: Stanford, California
- CMR Rate of Newly Diagnosed CML-CP Patients Treated With Nilotinib
Conditions: Chronic Myelogenous Leukemia in Chronic Phase
Location: Concord, California
- Safety & Efficacy Study of Oral Panobinostat (LBH589) With Chemotherapy in Patients < 65 Years Old With Acute Myeloid Leukemia (AML)
Conditions: Acute Myeloid Leukemia (AML)
Location: Stanford, California
- A Study of Escalating Doses of DCDS4501A in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia and DC
Conditions: Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia
Location: Stanford, California
- Caspofungin Acetate or Fluconazole in Preventing Invasive Fungal Infections in Patients With Acute Myeloid Leukemia Who Are Undergoing Chemotherapy
Conditions: Fungal Infection - Leukemia - Neutropenia
Location: San Francisco, California
- Phase 1/2 Safety and Efficacy of PLX3397 in Adults With Relapsed or Refractory Acute Myeloid Leukemia (AML)
Conditions: Acute Myeloid Leukemia
Location: San Francisco, California
- Levofloxacin in Preventing Infection in Young Patients Receiving Chemotherapy For Acute Leukemia or Undergoing Stem Cell Transplantation
Conditions: Bacterial Infection - Leukemia - Musculoskeletal Complications - Neutropenia
Location: San Francisco, California
- Bortezomib and Sorafenib Tosylate in Patients With Newly Diagnosed Acute Myeloid Leukemia With or Without Mutations
Conditions: Adult Acute Erythroid Leukemia (M6) - Adult Acute Megakaryoblastic Leukemia (M7) - Adult Acute Minimally Differentiated Myeloid Leukemia (M0) - Adult Acute Monoblastic Leukemia (M5a) - Adult Acute Monocytic Leukemia (M5b) - Adult Acute Myeloblastic Leukem
Location: Oakland, California
- Bortezomib and Sorafenib Tosylate in Patients With Newly Diagnosed Acute Myeloid Leukemia With or Without Mutations
Conditions: Adult Acute Erythroid Leukemia (M6) - Adult Acute Megakaryoblastic Leukemia (M7) - Adult Acute Minimally Differentiated Myeloid Leukemia (M0) - Adult Acute Monoblastic Leukemia (M5a) - Adult Acute Monocytic Leukemia (M5b) - Adult Acute Myeloblastic Leukem
Location: Oakland, California
- Bortezomib and Sorafenib Tosylate in Patients With Newly Diagnosed Acute Myeloid Leukemia With or Without Mutations
Conditions: Adult Acute Erythroid Leukemia (M6) - Adult Acute Megakaryoblastic Leukemia (M7) - Adult Acute Minimally Differentiated Myeloid Leukemia (M0) - Adult Acute Monoblastic Leukemia (M5a) - Adult Acute Monocytic Leukemia (M5b) - Adult Acute Myeloblastic Leukem
Location: San Francisco, California
- Temsirolimus, Dexamethasone, Mitoxantrone Hydrochloride, Vincristine Sulfate, and Pegaspargase in Treating Young Patients With Relapsed Acute Lymphobl
Conditions: B-cell Childhood Acute Lymphoblastic Leukemia - Peripheral T-cell Lymphoma - Recurrent Childhood Acute Lymphoblastic Leukemia - Recurrent Childhood Lymphoblastic Lymphoma - T-cell Childhood Acute Lymphoblastic Leukemia
Location: San Francisco, California
- Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Conditions: Cognitive/Functional Effects - Leukemia - Neurotoxicity - Pain - Therapy-related Toxicity
Location: Oakland, California
- Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Conditions: Cognitive/Functional Effects - Leukemia - Neurotoxicity - Pain - Therapy-related Toxicity
Location: San Francisco, California
- A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
Conditions: Lymphoblastic Leukemia, Acute, Childhood - Myelogenous Leukemia, Acute, Childhood
Location: San Francisco, California
- Decitabine With or Without Bortezomib in Treating Older Patients With Acute Myeloid Leukemia
Conditions: Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome - Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities - Adult Acute Myeloid Leukemia With Del(5q) - Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) - Seconda
Location: Mountain View, California
- A Study of CDX-1127 in Patients With Select Solid Tumor Types or Hematologic Cancers
Conditions: CD27 Expressing B-cell Malignancies - CD27 Expressing Solid Tumors - Chronic Lymphocytic Leukemia - Burkett's Lymphoma - Mantle Cell Lymphoma - Primary Lymphoma of the Central Nervous System - Marginal Zone B Cell Lymphoma - Solid Tumor - Metastatic Melan
Location: Stanford, California
- Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Conditions: Leukemia, Pediatric
Location: Palo Alto, California
- Acupuncture Point Stimulation for Treatment of Chemotherapy Nausea and Vomiting
Conditions: Childhood Acute Lymphoblastic Leukemia - Childhood Acute Myeloid Leukemia/Other Myeloid Malignancies - Ewing Sarcoma - Vomiting in Infants and/or Children - Osteosarcoma
Location: Stanford, California
- Donor Peripheral Stem Cell Transplant in Treating Patients With Hematolymphoid Malignancies
Conditions: Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) - Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) - Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) - Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) - Adult Nasal Type Extranodal NK/T-cell Lym
Location: Stanford, California
- Combination Chemotherapy With or Without Rituximab in Treating Younger Patients With Stage III-IV Non-Hodgkin Lymphoma or B-Cell Acute Leukemia
Conditions: Leukemia - Lymphoma
Location: San Francisco, California
- Double Cord Versus Haploidentical (Blood and Marrow Transplant Clinical Trials Network #1101)
Conditions: Acute Lymphocytic Leukemia - Acute Myelogenous Leukemia - Burkitt's Lymphoma - Follicular Lymphoma - Hodgkin Lymphoma - Mantle Cell Lymphoma
Location: Stanford, California
- Sorafenib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Leukemia
Conditions: Blastic Phase Chronic Myelogenous Leukemia - Childhood Acute Promyelocytic Leukemia (M3) - Childhood Chronic Myelogenous Leukemia - Chronic Myelogenous Leukemia, BCR-ABL1 Positive - Juvenile Myelomonocytic Leukemia - Philadelphia Chromosome Negative Chron
Location: Palo Alto, California
- Phase I/II MAHCT w/ TCell Depleted Graft w/ Simultaneous Infusion Conventional and Regulatory T Cell
Conditions: Myeloid Leukemia, Chronic - Acute Myelogenous Leukemia - Myelodysplastic Syndromes (MDS) - Lymphoma, Non-Hodgkin
Location: Palo Alto, California
- Bortezomib and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
Conditions: B-cell Adult Acute Lymphoblastic Leukemia - Ph Positive Adult Acute Lymphoblastic Leukemia - Recurrent Adult Acute Lymphoblastic Leukemia - T-cell Adult Acute Lymphoblastic Leukemia
Location: Stanford, California
- Bone Marrow Grafting for Leukemia and Lymphoma
Conditions: Leukemia - Lymphoma - Hematologic Diseases
Location: Stanford, California
- Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia
Conditions: Leukemia
Location: Oakland, California
- Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia
Conditions: Leukemia
Location: San Francisco, California
- Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
Conditions: Contiguous Stage II Adult Lymphoblastic Lymphoma - Noncontiguous Stage II Adult Lymphoblastic Lymphoma - Stage II Adult T-cell Leukemia/Lymphoma - Stage II Childhood Lymphoblastic Lymphoma - Stage III Adult Lymphoblastic Lymphoma - Stage III Adult T-cell
Location: Oakland, California
- Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
Conditions: Contiguous Stage II Adult Lymphoblastic Lymphoma - Noncontiguous Stage II Adult Lymphoblastic Lymphoma - Stage II Adult T-cell Leukemia/Lymphoma - Stage II Childhood Lymphoblastic Lymphoma - Stage III Adult Lymphoblastic Lymphoma - Stage III Adult T-cell
Location: Oakland, California
- Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
Conditions: Contiguous Stage II Adult Lymphoblastic Lymphoma - Noncontiguous Stage II Adult Lymphoblastic Lymphoma - Stage II Adult T-cell Leukemia/Lymphoma - Stage II Childhood Lymphoblastic Lymphoma - Stage III Adult Lymphoblastic Lymphoma - Stage III Adult T-cell
Location: Palo Alto, California
- Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
Conditions: Contiguous Stage II Adult Lymphoblastic Lymphoma - Noncontiguous Stage II Adult Lymphoblastic Lymphoma - Stage II Adult T-cell Leukemia/Lymphoma - Stage II Childhood Lymphoblastic Lymphoma - Stage III Adult Lymphoblastic Lymphoma - Stage III Adult T-cell
Location: San Francisco, California
- Clofarabine Plus Cytarabine Versus Conventional Induction Therapy And A Study Of NK Cell Transplantation In Newly Diagnosed Acute Myeloid Leukemia
Conditions: Acute Myeloid Leukemia
Location: Palo Alto, California
- Cyclosporine Eye Drops in Preventing Graft-Versus-Host Disease of the Eye in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Ca
Conditions: Chronic Myeloproliferative Disorders - Graft Versus Host Disease - Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms
Location: Palo Alto, California
- A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Followi
Conditions: B-cell Chronic Lymphocytic Leukemia
Location: Stanford, California
- Combination Chemotherapy With or Without Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia
Conditions: Adult Acute Lymphoblastic Leukemia in Remission - B-cell Adult Acute Lymphoblastic Leukemia - L1 Adult Acute Lymphoblastic Leukemia - L2 Adult Acute Lymphoblastic Leukemia - Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia - R
Location: Stanford, California
- Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Conditions: Myelodysplastic Syndromes - MDS - RAEB - Chronic Myelomonocytic Leukemia
Location: Stanford, California
- Dasatinib Followed by Stem Cell Transplant in Treating Older Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
Conditions: Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia - Untreated Adult Acute Lymphoblastic Leukemia
Location: Stanford, California
- Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD)
Conditions: GVHD - Adult Acute Myeloid Leukemia - Adult Acute Lymphoid Leukemia - Myelodysplastic Syndrome
Location: Stanford, California
- Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Chemotherapy for Leukemia
Conditions: Acute Myeloid Leukemia - Acute Lymphoblastic Leukemia - Chronic Myeloid Leukemia - Myelodysplasia
Location: San Francisco, California
- A Study Being Conducted at Multiple Locations to Compare the Safety and Effectiveness of Three Different Treatment Regimens; 1) Lenalidomide, 2) Lenal
Conditions: Acute Myeloid Leukemia - Acute Myelogenous Leukemia
Location: Stanford, California
- MRD Testing Before and After Hematopoietic Cell Transplantation Transplantation for Pediatric Acute Myeloid Leukemia
Conditions: Acute Myeloid Leukemia
Location: San Francisco, California
- Phase I Dose Finding and Proof-of-concept Study of Panobinostat With Standard Dose Cytarabine and Daunorubicin for Untreated Acute Myeloid Leukemia or
Conditions: Acute Myeloid Leukemia - Advanced Myelodysplastic Syndrome
Location: San Francisco, California
- Azacitidine With or Without Lenalidomide or Vorinostat in Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia
Conditions: Chronic Myelomonocytic Leukemia - de Novo Myelodysplastic Syndromes - Previously Treated Myelodysplastic Syndromes - Refractory Anemia With Excess Blasts - Secondary Myelodysplastic Syndromes
Location: Antioch, California
- Azacitidine With or Without Lenalidomide or Vorinostat in Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia
Conditions: Chronic Myelomonocytic Leukemia - de Novo Myelodysplastic Syndromes - Previously Treated Myelodysplastic Syndromes - Refractory Anemia With Excess Blasts - Secondary Myelodysplastic Syndromes
Location: Oakland, California
- Azacitidine With or Without Lenalidomide or Vorinostat in Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia
Conditions: Chronic Myelomonocytic Leukemia - de Novo Myelodysplastic Syndromes - Previously Treated Myelodysplastic Syndromes - Refractory Anemia With Excess Blasts - Secondary Myelodysplastic Syndromes
Location: Richmond, California
- Azacitidine With or Without Lenalidomide or Vorinostat in Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia
Conditions: Chronic Myelomonocytic Leukemia - de Novo Myelodysplastic Syndromes - Previously Treated Myelodysplastic Syndromes - Refractory Anemia With Excess Blasts - Secondary Myelodysplastic Syndromes
Location: San Francisco, California
- Azacitidine With or Without Lenalidomide or Vorinostat in Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia
Conditions: Chronic Myelomonocytic Leukemia - de Novo Myelodysplastic Syndromes - Previously Treated Myelodysplastic Syndromes - Refractory Anemia With Excess Blasts - Secondary Myelodysplastic Syndromes
Location: San Jose, California
- Azacitidine With or Without Lenalidomide or Vorinostat in Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia
Conditions: Chronic Myelomonocytic Leukemia - de Novo Myelodysplastic Syndromes - Previously Treated Myelodysplastic Syndromes - Refractory Anemia With Excess Blasts - Secondary Myelodysplastic Syndromes
Location: San Rafael, California
- Azacitidine With or Without Lenalidomide or Vorinostat in Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia
Conditions: Chronic Myelomonocytic Leukemia - de Novo Myelodysplastic Syndromes - Previously Treated Myelodysplastic Syndromes - Refractory Anemia With Excess Blasts - Secondary Myelodysplastic Syndromes
Location: Santa Clara, California
- Azacitidine With or Without Lenalidomide or Vorinostat in Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia
Conditions: Chronic Myelomonocytic Leukemia - de Novo Myelodysplastic Syndromes - Previously Treated Myelodysplastic Syndromes - Refractory Anemia With Excess Blasts - Secondary Myelodysplastic Syndromes
Location: South San Francisco, California
- Azacitidine With or Without Lenalidomide or Vorinostat in Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia
Conditions: Chronic Myelomonocytic Leukemia - de Novo Myelodysplastic Syndromes - Previously Treated Myelodysplastic Syndromes - Refractory Anemia With Excess Blasts - Secondary Myelodysplastic Syndromes
Location: Walnut Creek, California
- A Randomized, Double-Blind and Placebo-Controlled Study of Idelalisib in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemi
Conditions: Chronic Lymphocytic Leukemia
Location: Stanford, California
- A Extension Study of Idelalisib for Patients With Chronic Lymphocytic Leukemia Who Participated in GS-US-312-0116
Conditions: Chronic Lymphocytic Leukemia
Location: Stanford, California
- A Randomized, Double-Blind and Placebo-Controlled Study of Idelalisib in Combination With Bendamustine and Rituximab for Previously Treated Chronic Ly
Conditions: Chronic Lymphocytic Leukemia
Location: Palo Alto, California
- A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
Conditions: Relapsed or Refractory Chronic Lymphocytic Leukemia - Small Lymphocytic Lymphoma
Location: Stanford, California
- A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy
Conditions: Acute Lymphoblastic Leukemia - Lymphoblastic Lymphoma
Location: Palo Alto, California
- Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
Conditions: Chronic Myeloid Leukemia
Location: Pleasant Hill, California
- Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
Conditions: Chronic Myeloid Leukemia
Location: Pleasant Hill, California
- Phase III Study of CPX-351 Versus 7+3 in Patients 60-75 Years Old With Untreated High Risk (Secondary) Acute Myeloid Leukemia
Conditions: High Risk Acute Myeloid Leukemia
Location: Stanford, California
- A Multicenter, Open-label, Phase 3 Study of the Bruton's Tyrosine Kinase Inhibitor PCI-32765 Versus Chlorambucil in Patients 65 Years or Older With Tr
Conditions: Chronic Lymphocytic Leukemia - Small Lymphocytic Lymphoma
Location: Stanford, California
- An Open-label Extension Study in Patients 65 Years or Older With Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) Who Participat
Conditions: Chronic Lymphocytic Leukemia - Small Lymphocytic Lymphoma
Location: Stanford, California
- A Safety Study of SGN-CD19A for B-Cell Lymphoma
Conditions: Burkitt Lymphoma - Lymphoma, Follicular - Lymphoma, Large B-Cell, Diffuse - Lymphoma, Mantle-Cell - Precursor B-cell Lymphoblastic Leukemia-Lymphoma
Location: Stanford, California
- Cytarabine and Daunorubicin Hydrochloride or Idarubicin and Cytarabine With or Without Vorinostat in Treating Younger Patients With Previously Untreat
Conditions: Adult Acute Megakaryoblastic Leukemia (M7) - Adult Acute Monoblastic Leukemia (M5a) - Adult Acute Monocytic Leukemia (M5b) - Adult Acute Myeloblastic Leukemia With Maturation (M2) - Adult Acute Myeloblastic Leukemia Without Maturation (M1) - Adult Acute M
Location: Stanford, California
|